WO2000054747A3 - Method for treating dry eye - Google Patents
Method for treating dry eye Download PDFInfo
- Publication number
- WO2000054747A3 WO2000054747A3 PCT/US2000/006794 US0006794W WO0054747A3 WO 2000054747 A3 WO2000054747 A3 WO 2000054747A3 US 0006794 W US0006794 W US 0006794W WO 0054747 A3 WO0054747 A3 WO 0054747A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- eye
- dry eye
- treating dry
- compositions
- dry
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/717—Celluloses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Ophthalmology & Optometry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU37478/00A AU3747800A (en) | 1999-03-18 | 2000-03-15 | Method for treating dry eye |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12495399P | 1999-03-18 | 1999-03-18 | |
US60/124,953 | 1999-03-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000054747A2 WO2000054747A2 (en) | 2000-09-21 |
WO2000054747A3 true WO2000054747A3 (en) | 2000-12-21 |
Family
ID=22417580
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/006794 WO2000054747A2 (en) | 1999-03-18 | 2000-03-15 | Method for treating dry eye |
Country Status (3)
Country | Link |
---|---|
AR (1) | AR022960A1 (en) |
AU (1) | AU3747800A (en) |
WO (1) | WO2000054747A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6348508B1 (en) * | 2000-04-04 | 2002-02-19 | Bausch & Lomb Incorporated | Method for treating dry eye |
MXPA02010749A (en) * | 2000-05-02 | 2003-09-25 | Bausch & Lomb | Low ionic strength ophthalmic compositions. |
EP1421974B1 (en) * | 2002-06-10 | 2006-12-06 | D.M.G. Italia Srl | Carboxy methyl beta-1, 3 glucan containing ophthalmic solution |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3440352A1 (en) * | 1984-11-05 | 1986-05-07 | Dr. Thilo & Co GmbH, 8029 Sauerlach | Dry-eye packing |
WO1995000616A1 (en) * | 1993-06-18 | 1995-01-05 | Polymer Technology Corporation | Composition for wetting contact lenses |
WO2000037048A1 (en) * | 1998-12-22 | 2000-06-29 | Bausch & Lomb Incorporated | Method for treating extended-wear contact lenses in the eyes |
-
2000
- 2000-03-15 WO PCT/US2000/006794 patent/WO2000054747A2/en active Application Filing
- 2000-03-15 AU AU37478/00A patent/AU3747800A/en not_active Abandoned
- 2000-03-17 AR ARP000101177 patent/AR022960A1/en unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3440352A1 (en) * | 1984-11-05 | 1986-05-07 | Dr. Thilo & Co GmbH, 8029 Sauerlach | Dry-eye packing |
WO1995000616A1 (en) * | 1993-06-18 | 1995-01-05 | Polymer Technology Corporation | Composition for wetting contact lenses |
WO2000037048A1 (en) * | 1998-12-22 | 2000-06-29 | Bausch & Lomb Incorporated | Method for treating extended-wear contact lenses in the eyes |
Also Published As
Publication number | Publication date |
---|---|
AU3747800A (en) | 2000-10-04 |
AR022960A1 (en) | 2002-09-04 |
WO2000054747A2 (en) | 2000-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2403869A1 (en) | Method for treating dry eye | |
BRPI0416809A (en) | glycosamine | |
CA2206837A1 (en) | Use of strontium salts to obtain pharmaceutical compositions intented for the treatment of arthrosis | |
CA2236021A1 (en) | Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities: process of making metho ds of using and compositions thereof | |
BR9916879A (en) | Composition and method for treating cancer using natural vegetable essential oils | |
EP1281722A4 (en) | Hyaluronic acid gel, process for producing the same, and medical material containing the same | |
BR0314163A (en) | Compositions for the treatment of rigid surfaces | |
BR9808396A (en) | Process for increasing the deposition of a beneficial agent of a bar, and, bar composition | |
EP0335115A3 (en) | Pharmaceutical and cosmetical compositions on the base of benzoyl peroxide and quaternary ammonium salts | |
CA2199844A1 (en) | Compositions for the treatment of skin disorders | |
WO1998026770A3 (en) | The topical use of kappa opioid agonists to treat ocular pain | |
IL136101A0 (en) | Pharmaceutical compositions containing azelaic acid | |
AU2804500A (en) | Liquid cleansing composition | |
WO2000054747A3 (en) | Method for treating dry eye | |
WO2003039453A3 (en) | Novel benzoyl peroxide compositions for the treatment of dermatological disorders and methods for their use | |
BR9915955A (en) | Cosmetic composition for skin care, cosmetic process to treat aged skin and use of 4-chromanone | |
CA2294207A1 (en) | Anti-chlamydia agent | |
PL348781A1 (en) | Soya extract containing lipids, process for its production, and pharmaceutical and cosmetic composition | |
CA2180846A1 (en) | Method of treating disorders of the eye | |
PL338673A1 (en) | Application of fanquinone in treating alzheimer disease | |
AU687906B2 (en) | Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension | |
WO2001015677A3 (en) | Use of 5-ht1b/1d agonists to treat otic pain | |
CN108379189A (en) | A kind of face cream and preparation method thereof | |
EP0791357A3 (en) | Use of gluten peptides as stimulator of mineral absorption and preventive agent of hyperlipidermia and hypercholesterolemia | |
IL111805A0 (en) | Pharmaceutical compositions comprising dimeticone for the treatment of aphthae |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AU BA BB BG BR CA CN CU CZ EE GD GE HR HU ID IL IN IS JP KP KR LC LK LR LT LV MG MK MN MX NO NZ PL RO SG SI SK SL TR TT UA UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AU BA BB BG BR CA CN CU CZ EE GD GE HR HU ID IL IN IS JP KP KR LC LK LR LT LV MG MK MN MX NO NZ PL RO SG SI SK SL TR TT UA UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
122 | Ep: pct application non-entry in european phase |